References
- Loken MR, Voigt AP, Eidenschink Brodersen L, et al. Consistent quantitative gene product expression: #3. Invariance with age. Cytometry A. 2016;89:997–1000.
- Loken MR, Voigt AP, Eidenschink Brodersen L, et al. Consistent quantitative gene product expression: #2. Antigen intensities on bone marrow cells are invariant between individuals. Cytometry A. 2016;89:987–996.
- Pollard JA, Loken M, Gerbing RB, et al. CD33 expression and its association with gemtuzumab ozogamicin response: results from the randomized phase III Children’s Oncology Group Trial AAML0531. JCO. 2016;34:747–755.
- Lamba JK, Chauhan L, Shin M, et al. CD33 Splicing polymorphism determines gemtuzumab ozogamicin response in de novo AML: report from randomized phase III Children’s Oncology Group Trial AAML0531. JCO. 2017;35:2674–2682.
- Malik M, Chiles J 3rd, Xi HS, et al. Genetics of CD33 in Alzheimer’s disease and acute myeloid leukemia. Hum Mol Genet. 2015;24:3557–3570.
- Malik M, Simpson JF, Parikh I, et al. CD33 Alzheimer’s risk-altering polymorphism, CD33 expression, and exon 2 splicing. J Neurosci. 2013;33:13320–13325.
- Raj T, Ryan KJ, Replogle JM, et al. CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer’s disease susceptibility. Hum Mol Genet. 2014;23:2729–2736.
- Gamis AS, Alonzo TA, Meshinchi S, et al. Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531. JCO. 2014;32:3021–3032.
- Loken MR, Alonzo TA, Pardo L, et al. Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children’s Oncology Group. Blood. 2012;120:1581–1588.
- Voigt AP, Eidenschink Brodersen L, Pardo L, et al. Consistent quantitative gene product expression: #1. Automated identification of regenerating bone marrow cell populations using support vector machines. Cytometry A. 2016;89:978–986.
- Poncelet P, George F, Papa S, et al. Quantitation of hemopoietic cell antigens in flow cytometry. Eur J Histochem. 1996;40 (Suppl 1):15–32.
- Loken MR. Quantized hematopoiesis. In: Emadi A, Karp JE, editors. Acute leukemia. New York: Demosmedical; 2018. p. 243.
- Mortland L, Alonzo TA, Walter RB, et al. Clinical significance of CD33 nonsynonymous single-nucleotide polymorphisms in pediatric patients with acute myeloid leukemia treated with gemtuzumab-ozogamicin-containing chemotherapy. Clin Cancer Res. 2013;19:1620–1627.